Campbell’s Co (NASDAQ:CPB) on Thursday reported worse-than-expected fourth-quarter sales results and issued FY27 adjusted EPS guidance below estimates.

Adjusted EPS of 39 cents was in line with estimates. Sales of $2.137 billion missed the $2.146 billion consensus estimate.

For fiscal 2027, Campbell’s expects adjusted EPS of $1.65 to $1.80, below the $1.85 analyst estimate. The company expects organic net sales in Meals & Beverages to decline about 3% at the midpoint in the first quarter. It expects performance to remain relatively consistent throughout the year.

“Fourth quarter and fiscal 2026 results reflect top-line softness and inflation-driven margin headwinds,” said Mick Beekhuizen, Campbell’s President and Chief Executive Officer. “Our performance is not where it needs to be, and we are taking decisive action to improve it.”

Campbell’s shares fell 2.9% to trade at $21.48 on Friday.

These analysts made changes to their price targets on Campbell’s following earnings announcement.

• Jefferies analyst Scott Marks maintained the stock with a Hold and lowered the price target from $22 to $20.
• Barclays analyst Andrew Lazar maintained the stock with an Underweight rating and cut the price target from $19 to $18.
• UBS analyst Peter Grom maintained the stock with a Sell and raised the price target from $18 to $19.
• RBC Capital analyst Nik Modi maintained the stock with a Sector Perform and cut the price target from $21 to $19.

Considering buying CPB stock? Here’s what analysts think:

Photo via Shutterstock